Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2025 ,inter alia, to consider and approve the proposal for ....
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Agarwals Eye Hospital has called a Board meeting on August 27, 2025 to consider raising up to ₹70 crore by issuing equity shares to its promoter, Dr. Agarwal's Health Care Limited, through a preferential allotment. This is a prior intimation under SEBI Listing Regulations, and the proposal will also need shareholder approval at the upcoming Annual General Meeting. The trading window for the stock is closed from August 24 until 48 hours after the Board meeting outcome is disclosed. Since this is a promoter-driven fundraise rather than a market offering, the pricing will be determined as per SEBI ICDR Regulations.
Existing shareholders will face dilution due to the issuance of new shares to the promoter, but the ₹70 crore infusion strengthens the company's capital base and signals promoter confidence in the business. The stock may see some pressure on the news due to dilution concerns, though promoter backing is generally viewed positively.